Table 4.

Hazard Ratios Associated with Selected Risk factors for Endometrial Cancer, BRCA2 carriers only

Variables	Univariate OR (95%CI) P-value	Multivariate OR (95%CI) P-value
Age at baseline questionnaire	1.00 (0.90–1.13) 0.95	1.06 (0.91–1.24) 0.47
Parity (mean)	1.19 (0.80–1.76) 0.39	1.42 (0.85–2.39) 0.19
Tamoxifen (any use)
No	1	1
Yes	3.28 (0.52–20.6) 0.21	6.17 (0.42–91.3) 0.18
Tamoxifen
Brest cancer
patients only
No	1	1
Yes	3.77 (0.60–23.6) 0.16	19.2 (0.4–1758) 0.20
Menopausal status
Premenopausal	Not applicable	Not applicable
Postmenopausal
HRT
No	1	1
Yes	0.59 (0.15–2.27) 0.44	0.18 (0.02–1.76) 0.14
E	0	0
P	0	0
EP	1.29 (0.26–6.49) 0.76	0.35 (0.02–5.15) 0.44
Oral contraceptives
No	1	1
Yes	2.45 (0.50–12.1) 0.27	6.19 (0.61–62.6) 0.12
Smoking history
Never	1	1
Ever	0.60 (0.21–1.77) 0.36	1.26 (0.34–4.74) 0.73
BMI18	0.97 (0.73–1.29) 0.85	0.89 (0.61–1.31) 0.56
BMI30	0.63 (0.40–0.98) 0.04	0.41 (0.18–0.97) 0.04
BMI40	1.32 (1.00–1.75) 0.05	1.61 (1.06–2.45) 0.02